astemizole has been researched along with diethylnitrosamine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Acuña-Macías, I; Camacho, J; Caro-Sánchez, CH; Chiliquinga, AJ; de Guadalupe Chávez-López, M; Díaz-Chávez, J; Gariglio, P; Hernández-Gallegos, E; Herrera, LA; Pérez-Carreón, JI; Zuñiga-García, V | 1 |
1 other study(ies) available for astemizole and diethylnitrosamine
Article | Year |
---|---|
Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC.
Topics: Animals; Apoptosis; Astemizole; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Proliferation; Diethylnitrosamine; Ether-A-Go-Go Potassium Channels; gamma-Glutamyltransferase; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Neoplasm Staging; Prognosis; Rats | 2015 |